Valence Logo
Popular
Login
Loading data for RCKTW — first visit, this takes a few seconds.

Add to Watchlist

Rocket Pharmaceuticals In...

NasdaqCM: RCKTW · Real-Time Price · USD
0.00
n/a (n/a)
At close: Aug 21, 2026, 7:47 PM

The price, the headline numbers and the latest news, in one place.

Rocket Pharmaceuticals Inc. (RCKTW) Stock Price, Analysis & Data

No data available

Bidn/a
Market Capn/a
Revenue (ttm)n/a
Net Income (ttm)n/a
n/a
n/a
n/a
n/a
P/B (ttm)n/a
P/S (ttm)n/a
Earnings Daten/a
Askn/a
Volume66,885
Avg. Volume (20D)
Open0.03
Previous Closen/a
Day's Rangen/a - n/a
52-Week Rangen/a - n/a
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About RCKTW

A detailed description of the company is not yet available....

[Read more]
Industry n/a
Sector n/a
IPO Date Jul 17, 2026
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol RCKTW
Full Company Profile

Financial Performance

In 2025, Rocket Pharmaceuticals's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -223.12M, a decrease of -13.77%.

Financial Statements
news image

1 week ago · Zacks

Rocket Pharmaceuticals Q2 Earnings Rise Y/Y, Kresladi Launch in Focus

RCKT records earnings growth in the second quarter. Kresladi launch preparations advance and RP-A501 safety findings support its next development steps.

news image

1 week ago · MT Newswires

Rocket Pharmaceuticals' Danon, PKP2-ACM Updates Seen as Key H2 Catalysts, Wedbush Says

Rocket Pharmaceuticals' (RCKT) Q2 update confirmed its programs are on track, with management expect

news image

1 month ago · Insider Monkey

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone?

We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is one of the most promising stocks on our list. TheFl...

news image

3 months ago · Insider Monkey

Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going?

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) is one of the best gene therapy stocks to buy in 2026. The Street expects Rocket Pharmaceuticals’ stock to explode 180% over the next 12 months. On April 28, L...

news image

3 months ago · Insider Monkey

Rocket Pharmaceuticals (RCKT) Reports Q1 2026 Net Loss of $47.6M

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy right now. On May 7, Rocket Pharmaceuticals reported a Q1 2026 net loss of $47.6 million ($0.42 per share). D...

Page 1 of 2